TORONTO, ONTARIO--(Marketwired - May 6, 2016) - NEXGENRX INC. (TSX VENTURE:NXG) ("NexgenRx" or the "Corporation") announces that it has immediately instituted special provisions to assist plan members affected by the Fort McMurray fires. Given the severity of the situation, NexgenRx will be removing the "Refill Too Soon" edit check, allowing members to access their medications that were lost or abandoned. Members are urged to visit any location of their pharmacy chain who can access their prescription on file, which will then be filled and submitted for approval by NexgenRx. If that is not possible, members can contact their physician and have a new prescription faxed to any other pharmacy for dispensing. The NexgenRx provider help desk can be reached toll free at 1-866-394-3648 for further assistance.

"Our thoughts and prayers are with all residents and our plan members affected by this tragedy in Fort McMurray and surrounding areas. We are committed to assisting wherever needed," stated Ron Loucks, President & CEO of NexgenRx.

About NexgenRx

NexgenRx is Canada's only independent full service claims adjudicator with full front end administration capability. These combined capabilities allow NexgenRx to provide complete solutions to plan sponsors that need sophisticated health benefit technology applications, in a cost-effective manner. NexgenRx is committed to building partnerships with organizations looking to exceed the expectations of their clients and deliver superior administration and claims processing solutions at a competitive cost. More information on NexgenRx can be found at

Caution Regarding Forward-Looking Statements - This news release contains certain forward looking statements of the Corporation. These statements are subject to a number of risks and uncertainties. Actual results may differ materially from results contemplated by the forward-looking statements. When relying on forward-looking statements to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and should not place undue reliance on such forward-looking statements.

"Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the release."

Contact Information:

Ronald C. Loucks
NexgenRx Inc.
President and CEO
416.695.3393 x801

Taba Merrikh
NexgenRx Inc.
Director of Finance